Evidence map›Paper›PMID 39433808›Full record

ArticleScientific reports2024

Identifying pathogenic variants in rare pediatric neurological diseases using exome sequencing.

Kazuyuki Komatsu, Mitsuhiro Kato, Kazuo Kubota, Shinobu Fukumura, Keitaro Yamada, Ikumi Hori, Kenji Shimizu, Sachiko Miyamoto, Kaori Yamoto, Takuya Hiraide and 8 more

Abstract read
In one paragraph

Article in Scientific reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Kazuyuki KomatsuDepartment of Biochemistry, Hamamatsu University School of Medicine, Hamamatsu, 431- 3192, Japan.
Mitsuhiro KatoDepartment of Pediatrics, Showa University School of Medicine, Tokyo, 142-8555, Japan.
Kazuo KubotaDepartment of Pediatrics, Gifu University Graduate School of Medicine, Gifu, 501-1194, Japan.
Shinobu FukumuraDepartment of Pediatrics, Sapporo Medical University School of Medicine, Sapporo, 060-8556, Japan.
Keitaro YamadaDepartment of Pediatric Neurology, Central Hospital, Aichi Developmental Disability Center, Kasugai, 486-0392, Japan.
Ikumi HoriDepartment of Pediatrics and Neonatology, Nagoya City University Graduate School of Medical Sciences, Nagoya, 467-8601, Japan.
Kenji ShimizuDivision of Medical Genetics, Shizuoka Children's Hospital, Shizuoka, 420-8660, Japan.
Sachiko MiyamotoDepartment of Biochemistry, Hamamatsu University School of Medicine, Hamamatsu, 431- 3192, Japan.
Kaori YamotoDepartment of Biochemistry, Hamamatsu University School of Medicine, Hamamatsu, 431- 3192, Japan.
Takuya HiraideDepartment of Pediatrics, Hamamatsu University School of Medicine, Hamamatsu, 431-3192, Japan.
Kazuki WatanabeDepartment of Neurology, Hamamatsu University School of Medicine, Hamamatsu, 431-3192, Japan.
Shintaro AokiDepartment of Biochemistry, Hamamatsu University School of Medicine, Hamamatsu, 431- 3192, Japan.
Shogo FurukawaDepartment of Biochemistry, Hamamatsu University School of Medicine, Hamamatsu, 431- 3192, Japan.
Taiju HayashiDepartment of Biochemistry, Hamamatsu University School of Medicine, Hamamatsu, 431- 3192, Japan.
Masaharu IsogaiDepartment of Biochemistry, Hamamatsu University School of Medicine, Hamamatsu, 431- 3192, Japan.
Takuma HarasakiDepartment of Biochemistry, Hamamatsu University School of Medicine, Hamamatsu, 431- 3192, Japan.
Mitsuko NakashimaDepartment of Biochemistry, Hamamatsu University School of Medicine, Hamamatsu, 431- 3192, Japan.
Hirotomo SaitsuDepartment of Biochemistry, Hamamatsu University School of Medicine, Hamamatsu, 431- 3192, Japan. hsaitsu@hama-med.ac.jp.

Funding

Japan Agency for Medical Research and Development JP23ek0109549Japan Society for the Promotion of Science JP20H03641
6 · The paper itself

Abstract

Variant annotations are crucial for efficient identification of pathogenic variants. In this study, we retrospectively analyzed the utility of four annotation tools (allele frequency, ClinVar, SpliceAI, and Phenomatcher) in identifying 271 pathogenic single nucleotide and small insertion/deletion variants (SNVs/small indels). Although variant filtering based on allele frequency is essential for narrowing down on candidate variants, we found that 13 de novo pathogenic variants in autosomal dominant or X-linked dominant genes are registered in gnomADv4.0 or 54KJPN, with an allele frequency of less than 0.001%, suggesting that very rare variants in large cohort data can be pathogenic de novo variants. Notably, 38.4% candidate SNVs/small indels are registered in the ClinVar database as pathogenic or likely pathogenic, which highlights the significance of this database. SpliceAI can detect candidate variants affecting RNA splicing, leading to the identification of four variants located 11 to 50 bp away from the exon-intron boundary. Prioritization of candidate genes by proband phenotype using the PhenoMatcher module revealed that approximately 95% of the candidate genes had a maximum PhenoMatch score ≥ 0.6, suggesting the utility of phenotype-based variant prioritization. Our results suggest that a combination of multiple annotation tools and appropriate evaluation can improve the diagnosis of rare diseases.

Indexed as

Exome SequencingNervous System DiseasesChildDatabases, GeneticExomeFemaleGene FrequencyGenetic Predisposition to DiseaseHumansINDEL MutationMaleMolecular Sequence AnnotationPhenotypePolymorphism, Single NucleotideRare DiseasesRetrospective StudiesAnnotationDe novo variantExome sequencingNeurological rare diseasesSplicing abnormality

Identifiers

PMID39433808
PMCPMC11494122

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.